Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma. - Wikidata - wikimedia - TriplyDB

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

http://www.wikidata.org/entity/Q42041007

about

Zinc and zinc transporters in prostate carcinogenesis Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat model Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis.Serum zinc and prostate cancer risk in a nested case-control study: The multiethnic cohort Status and Interrelationship of Zinc, Copper, Iron, Calcium and Selenium in Prostate Cancer Cooperative stabilization of Zn(2+):DNA complexes through netropsin binding in the minor groove of FdU-substituted DNA.Zinc transporters and dysregulated channels in cancers.Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus Increased zinc accumulation in mineralized osteosarcoma tissue measured by confocal synchrotron radiation micro X-ray fluorescence analysis.Zinc status in benign prostatic hyperplasia and prostate carcinoma.Elevated seminal plasma estradiol and epigenetic inactivation of ESR1 and ESR2 is associated with CP/CPPS.

P2860

Q27010040-B553F8E6-0F7B-4F3F-9C68-C43F525EAE94 Q35843929-D9AC65B9-B9CB-48C4-BF90-B05CB1C99198 Q36015204-E6691E85-7BE4-4A85-876B-F2D585FD8422 Q36388829-1FF25600-0A91-403E-B013-875210AB2725 Q36515783-A9852CC1-5D93-4019-A364-7177942E5413 Q37301969-4C8CECDB-0C9E-4C79-91D1-5AC9971505D8 Q37545055-305C193B-4D02-4CC4-8F1E-AADA0079432E Q37607461-BB1F6597-CD22-4CF3-8BF9-559B4A01BFF1 Q37633403-25610667-9A79-4322-8FC7-52C0AE11B963 Q42073620-C87D099A-B07E-4EC5-A029-BBF12A44253D Q54962118-7B230862-F515-47D7-A838-3D4B0A669786

P2860

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

http://www.wikidata.org/entity/Q42041007

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

@en

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

@nl

type

label

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

@en

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

@nl

prefLabel

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

@en

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

@nl

P1433

Q42041007-54A53F06-5371-449F-9A52-362C8B12E78A

P1476

Q42041007-F550FCE8-E4FD-48BE-A66E-896B4B8C0F41

P2093

Q42041007-6499D219-8BAB-4E2D-849D-DA8F8470FA18

Q42041007-A9A1084E-17D7-49F6-8C0A-40B9D58F5DED

Q42041007-D0F1F356-59A4-4F1A-B64B-BD68BFB19491

Q42041007-E2C9763B-5FAD-41AA-8DE5-965CE60CCDD1

P2860

Q42041007-25CD55A2-F07F-4BF0-A78A-9DEB3F83133E

Q42041007-36FB82D4-9CD5-41CC-A41C-B6C90DBC2CF0

Q42041007-38E04776-B5CE-4A25-9DA2-5B2697E156B0

Q42041007-3C7A12D7-E6D2-4400-93A8-CA88F9F48B22

Q42041007-56612941-D5EC-4F69-829D-82A310236700

Q42041007-68FACE12-E2AC-4F81-8F6A-4EA0BCD2408E

Q42041007-965C6174-9DC9-4F17-828A-39599CB99317

Q42041007-9A3F7FED-1F5C-49E2-9DAA-0D5851A42120

Q42041007-B0757551-870C-45B1-B1D6-4A0E81870DB1

Q42041007-C3658BE1-950A-4B45-BF67-D28815E2DDBD

P304

Q42041007-A1230B1B-FA58-44BE-A307-40A1999F86E0

P31

Q42041007-5283D9D8-A346-4244-A675-C97EF58427A5

P356

Q42041007-E9E4B57F-5904-4FFB-8FF8-36C4A58F7CA6

P433

Q42041007-D677DB73-0B71-4F27-91E8-2DC88524F84B

P478

Q42041007-6123F61D-4A2C-41DB-B692-9DF635810C38

P577

Q42041007-16EE2E85-7495-435B-BAC9-B394DD82BCB3

P698

Q42041007-895C78E8-8BBC-4A0A-96D4-DDE40575E091

P932

Q42041007-3D61854D-B453-4E5D-A1F5-A2E299728AEF

P356

0970-1591.78405

P1433

Indian Journal of Urology

P1476

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.

@en

P2093

Ganesh Gopalakrishnan

http://www.w3.org/2001/XMLSchema#string

Joseph J Fleming

http://www.w3.org/2001/XMLSchema#string

Pamela Christudoss

http://www.w3.org/2001/XMLSchema#string

R Selvakumar

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots

hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor

Selenium, zinc, and prostate cancer.

Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression

Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer.

Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer.

Cancer of the prostate.

[Zinc levels in prostatic fluid of patients with prostate pathologies].

Clinical and experimental. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypogonadism. 1963.

P304

14-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0970-1591.78405

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21716879

http://www.w3.org/2001/XMLSchema#string

P932

3114577

http://www.w3.org/2001/XMLSchema#string